KYMERA THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
KYMERA THERAPEUTICS, INC. (KYMR) reported Basic Shares Outstanding (Weighted Average) of 98.18 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 98.18M shares, a 22.04% increase year-over-year.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 97.53M shares, a 21.69% increase year-over-year.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 90.00M shares, a 12.24% increase year-over-year.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 87.30M shares, a 14.68% increase year-over-year.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 84.49M shares, a 12.59% increase from fiscal 2024.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 75.04M shares, a 28.58% increase from fiscal 2023.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 58.37M shares, a 8.22% increase from fiscal 2022.
- KYMERA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 53.93M shares, a 12.39% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 98.18M shares 10-Q · filed 2026-08-05 | 97.86M shares 10-Q · filed 2026-08-05 | 95.24M shares derived: average of 3 quarters · filed 2026-08-05 | 93.25M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 97.53M shares 10-Q · filed 2026-04-30 | 93.77M shares derived: average of 2 quarters · filed 2026-04-30 | 91.61M shares derived: average of 3 quarters · filed 2026-04-30 | 88.82M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 90.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 88.65M shares derived: average of 2 quarters · filed 2026-02-26 | 85.92M shares derived: average of 3 quarters · filed 2026-08-05 | 84.49M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 87.30M shares 10-Q · filed 2025-11-04 | 83.87M shares derived: average of 2 quarters · filed 2026-08-05 | 82.65M shares 10-Q · filed 2025-11-04 | 82.02M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 80.45M shares 10-Q · filed 2026-08-05 | 80.30M shares 10-Q · filed 2026-08-05 | 80.26M shares derived: average of 3 quarters · filed 2026-08-05 | 79.23M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 80.15M shares 10-Q · filed 2026-04-30 | 80.17M shares derived: average of 2 quarters · filed 2026-04-30 | 78.82M shares derived: average of 3 quarters · filed 2026-04-30 | 77.38M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 80.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 78.16M shares derived: average of 2 quarters · filed 2026-02-26 | 76.46M shares derived: average of 3 quarters · filed 2026-02-26 | 75.04M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 76.13M shares 10-Q · filed 2025-11-04 | 74.59M shares derived: average of 2 quarters · filed 2025-11-04 | 73.33M shares 10-Q · filed 2025-11-04 | 69.62M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 73.06M shares 10-Q · filed 2025-08-11 | 71.91M shares 10-Q · filed 2025-08-11 | 67.45M shares derived: average of 3 quarters · filed 2026-02-26 | 65.19M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 70.77M shares 10-Q · filed 2025-05-09 | 64.65M shares derived: average of 2 quarters · filed 2026-02-26 | 62.57M shares derived: average of 3 quarters · filed 2026-02-26 | 61.51M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 58.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 58.47M shares derived: average of 2 quarters · filed 2026-02-26 | 58.42M shares derived: average of 3 quarters · filed 2026-02-26 | 58.37M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 58.42M shares 10-Q · filed 2024-10-31 | 58.37M shares derived: average of 2 quarters · filed 2024-10-31 | 58.31M shares 10-Q · filed 2024-10-31 | 58.22M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 58.33M shares 10-Q · filed 2024-08-07 | 58.26M shares 10-Q · filed 2024-08-07 | 58.15M shares derived: average of 3 quarters · filed 2025-02-27 | 57.25M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 58.19M shares 10-Q · filed 2024-05-02 | 58.06M shares derived: average of 2 quarters · filed 2025-02-27 | 56.89M shares derived: average of 3 quarters · filed 2025-02-27 | 55.61M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 57.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 56.23M shares derived: average of 2 quarters · filed 2025-02-27 | 54.75M shares derived: average of 3 quarters · filed 2025-02-27 | 53.93M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 54.54M shares 10-Q · filed 2023-11-02 | 53.15M shares derived: average of 2 quarters · filed 2023-11-02 | 52.60M shares 10-Q · filed 2023-11-02 | 52.35M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 51.77M shares 10-Q · filed 2023-08-03 | 51.71M shares 10-Q · filed 2023-08-03 | 51.62M shares derived: average of 3 quarters · filed 2024-02-22 | 51.39M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 51.65M shares 10-Q · filed 2023-05-04 | 51.54M shares derived: average of 2 quarters · filed 2024-02-22 | 51.27M shares derived: average of 3 quarters · filed 2024-02-22 | 49.72M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | 51.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 51.07M shares derived: average of 2 quarters · filed 2024-02-22 | 49.08M shares derived: average of 3 quarters · filed 2024-02-22 | 47.99M shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 50.71M shares 10-Q · filed 2022-11-03 | 47.90M shares derived: average of 2 quarters · filed 2022-11-03 | 46.84M shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 45.09M shares 10-Q · filed 2022-08-09 | 44.87M shares 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | 17.35M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |